PtBio
Latest round
- Series A
Last raised
- Oct 2023
Total raised
- $3.3M
Investors
- 6
About PtBio
a. PtBio, operates as a company that provides genome editing tool development, genome analysis services, bioinformatics, data driven breeding support, and bio manufacturing support, offering integrated research, development, and implementation services to partners in healthcare, agriculture, food, energy, and biotechnology sectors. PtBio Inc. specializes in advanced biotechnology solutions, primarily focusing on genome editing and BioDX services. Their core offerings include the development of Platinum TALENs and ZF-ND1 genome editing tools, enabling precise modifications in various organisms for applications in agriculture, aquaculture, and medical therapies. Additionally, they are involved in data-driven breeding practices for perilla plants, gene therapies for rare eye diseases, and the development of hypoallergenic eggs for those with egg allergies. Their innovations target diverse markets, including Japan, Southeast Asia, and potentially beyond. PtBio Inc. operates on a business-to-business (B2B) model, providing genomic services to sectors like agriculture, pharmaceuticals, and environmental management. The company engages in partnerships with research institutions, agricultural firms, and biotech companies to deliver tailored solutions. Revenue is generated through contracts for genome editing services, which may involve fixed project fees or milestone payments. The BioDX services may also operate on a subscription basis, providing clients with continuous access to data analytics. As of March 2026, the company plans to scale bio DX services, commercialize allergy reduced eggs, expand partnerships, advance gene therapy programs, and grow operations.
Who invested in PtBio
6 investors across 1 round
See all investors in PtBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 25, 2023
Amount
$3.3M
Investors
Questions about PtBio
Who invested in PtBio?
PtBio has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PtBio raised?
PtBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did PtBio last raise money?
PtBio's most recent round on record is a Series A, in Oct 2023.
What does PtBio do?
PtBio is a biotechnology company.
Where is PtBio headquartered?
PtBio is headquartered in Higashihiroshima, Japan.
Which VCs invest in companies like PtBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at PtBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like PtBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.